Clinical Trials Browser

OTHER × Melanoma × Celecoxib × Clear all

NCT04093323 2026-02-25

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

Phase 2 Terminated

Melanoma

NCT00197912 2010-04-26

Dendritic Cell Based Therapy of Malignant Melanoma

Phase 1/2 Completed

Melanoma